PRIME EQUINE Trademark

Trademark Overview


On Saturday, June 11, 2022, a trademark application was filed for PRIME EQUINE with the United States Patent and Trademark Office. The USPTO has given the PRIME EQUINE trademark a serial number of 97454216. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, July 14, 2023. This trademark is owned by Prime Equine Research LLC. The PRIME EQUINE trademark is filed in the Pharmaceutical Products category with the following description:

Pain relief medication
prime equine

General Information


Serial Number97454216
Word MarkPRIME EQUINE
Filing DateSaturday, June 11, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, July 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPain relief medication

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 23, 2022
Primary Code005
First Use Anywhere DateSunday, May 15, 2022
First Use In Commerce DateSunday, May 15, 2022

Trademark Owner History


Party NamePrime Equine Research LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressAstatula, FL 34705

Trademark Events


Event DateEvent Description
Monday, July 17, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, July 14, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, July 14, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 27, 2023NON-FINAL ACTION E-MAILED
Monday, March 27, 2023NON-FINAL ACTION WRITTEN
Wednesday, March 22, 2023ASSIGNED TO EXAMINER
Thursday, June 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 15, 2022NEW APPLICATION ENTERED

Related Keywords


equine prime medication relief pain